• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

    12/3/24 3:35:39 PM ET
    $LGMK
    Industrial Specialties
    Health Care
    Get the next $LGMK alert in real time by email
    SC 13D/A 1 tm2430073d1_sc13da.htm SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    SCHEDULE 13D

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 4)*

     

    LogicMark, Inc.

    (Name of Issuer)

     

    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

     

    67091J6021

    (CUSIP Number)

     

    The Winvest Investment Fund Management Corp.

    Skyline Tower 10900 NE 4th St, Floor 23

    Bellevue, WA 98004

    Attention: Jourdan Matthews

    Telephone: (425) 331-9885

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    November 22, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ¨.

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    1 This CUSIP Number is effective following a 1:25 reverse stock split of the Common Stock effected by the Issuer on November 18, 2024, as reported by the Issuer in a Form 8-K filed with the SEC on November 18, 2024.

     

     

     

    CUSIP No. 67091J602

     

    1.Names of Reporting Person

     

    The Winvest Investment Fund Management Corp.

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)¨

     

    3.SEC Use Only

     

    4.Source of Funds (See Instructions)

     

    WC

     

    5.Check Box if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e)

     

    ¨

     

    6.Citizenship or Place of Organization

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY EACH

    REPORTING

    PERSON WITH:

    7.  SOLE VOTING POWER 02
    8.  SHARED VOTING POWER 02
    9.  SOLE DISPOSITIVE POWER 02
    10.  SHARED DISPOSITIVE POWER 02

    11.Aggregate Amount Beneficially Owned by Such Reporting Person

     

    02

     

    12.Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨

     

    13.Percent of Class Represented by Amount in Row (11)

     

    0.0%2

     

    14.Type of Reporting Person (See Instructions)

     

    CO 

     

     

    2 This information is given as of the end of business on November 22, 2024, being the Event Date of this Amendment No. 4 to Schedule 13D, and remains accurate as of the end of business on December 3, 2024, being the filing date of this Amendment No. 4 to Schedule 13D.

     

     Page 2 of 6 Pages 

     

     

    CUSIP No. 67091J602

     

    1.Names of Reporting Person

     

    Mr. Jourdan Matthews

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)¨

      

    3.SEC Use Only

     

    4.Source of Funds (See Instructions)

     

    AF

     

    5.Check Box if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e)

     

    ¨

     

    6.Citizenship or Place of Organization

     

    United States of America

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY EACH

    REPORTING

    PERSON WITH:

    7.  SOLE VOTING POWER 02
    8.  SHARED VOTING POWER 02
    9.  SOLE DISPOSITIVE POWER 02
    10.  SHARED DISPOSITIVE POWER 02

    11.Aggregate Amount Beneficially Owned by Such Reporting Person

     

    02

     

    12.Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨

     

    13.Percent of Class Represented by Amount in Row (11)

     

    0.0%2

     

    14.Type of Reporting Person (See Instructions)

     

    IN

     

     Page 3 of 6 Pages 

     

     

    EXPLANATORY NOTE

     

    This Amendment No. 4 to Schedule 13D (this “Amendment No. 4” or this “Statement”) is being filed with respect to the beneficial ownership of Common Stock, par value $0.0001 per share (the “Common Stock”), of LogicMark, Inc. (the “Issuer”). This Amendment No. 4 amends and restates in its entirety Item 5 of the Schedule 13D originally filed on October 18, 2024, as amended by Amendment No. 1 thereto filed on October 29, 2024, Amendment No. 2 thereto filed on October 30, 2024, and Amendment No. 3 thereto filed on November 12, 2024 (“Amendment No. 3”).

     

    ITEM 5.Interest in Securities of the Issuer.

     

    (a)            As of the end of business on each of November 22, 2024 (the Event Date of this Amendment No. 4) and December 3, 2024 (the filing date of this Amendment No. 4), the Reporting Persons did not own any shares of Common Stock.

     

    (b)            Not applicable.

     

    (c)            No transactions in the Common Stock have been effected by the Reporting Persons since the filing date of Amendment No. 3, except as set forth in the table below. These transactions occurred following a 1:25 reverse stock split of the Common Stock effected by the Issuer on November 18, 2024, as reported by the Issuer in a Form 8-K filed with the SEC on November 18, 2024.

     

    Reporting
    Person
    Trade Date Type Number of
    Shares
    Price Per
    Share
    Winvest 11/22/2024 Open Market Sale 484 $1.7908
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7700
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7800
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7892
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7921
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8048
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8168
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7600
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7301
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7325
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7292
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7435
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7685
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7460
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8000
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7536
    Winvest 11/22/2024 Open Market Sale 2,500 $1.7990
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8063
    Winvest 11/22/2024 Open Market Sale 5,000 $1.7836
    Winvest 11/22/2024 Open Market Sale 5,000 $1.8212
    Winvest 11/22/2024 Open Market Sale 5,000 $1.7903
    Winvest 11/22/2024 Open Market Sale 5,000 $1.7910

     

     Page 4 of 6 Pages 

     

     

    Reporting
    Person
    Trade Date Type Number of
    Shares
    Price Per
    Share
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8001
    Winvest 11/22/2024 Open Market Sale 5,000 $1.7401
    Winvest 11/22/2024 Open Market Sale 5,000 $1.7711
    Winvest 11/22/2024 Open Market Sale 5,000 $1.8004
    Winvest 11/22/2024 Open Market Sale 5,000 $1.8046
    Winvest 11/22/2024 Open Market Sale 5,000 $1.8106
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8469
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8180
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8500
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8101
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8234
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8532
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8650
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8755
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8971
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8901
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9036
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9242
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9189
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9001
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8913
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9061
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8958
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8904
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8959
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9100
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9017
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9062
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9309
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9200
    Winvest 11/22/2024 Open Market Sale 2,500 $1.8801
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9302
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9501
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9859
    Winvest 11/22/2024 Open Market Sale 2,500 $1.9989

     

    (d)           Not applicable.

     

    (e)            On November 22, 2024, the Reporting Persons ceased to be beneficial owners of more than five percent of the Common Stock.

     

     Page 5 of 6 Pages 

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned each certifies that the information with respect to it set forth in this Statement is true, complete and correct.

     

    Dated: December 3, 2024

     

    The Winvest Investment Fund Management Corp.

     

    By:  /s/ Jourdan Matthews  

    Name: Jourdan Matthews

    Title: President

     

     

    /s/ Jourdan Matthews  

    Jourdan Matthews

     

     

     Page 6 of 6 Pages 

    Get the next $LGMK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LGMK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LGMK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Financial Officer Archer Mark

      4 - LogicMark, Inc. (0001566826) (Issuer)

      3/31/25 5:29:59 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Pettitt John P

      4 - LogicMark, Inc. (0001566826) (Issuer)

      3/31/25 5:29:32 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by President and CEO Simmons Chia-Lin

      4 - LogicMark, Inc. (0001566826) (Issuer)

      3/31/25 5:29:03 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Financials

    Live finance-specific insights

    See more
    • LogicMark, Inc. Reports Strong Third-Quarter 2024 Results Led by Double-Digit Growth in Year-Over-Year Sales and Gross Profit

      LOUISVILLE, Ky., Nov. 12, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced financial results for the third quarter ended September 30, 2024. Financial and Operational Highlights: Revenues rose to $2.7 million in the third quarter of 2024, a 14% year-over-year increase.Gross profit increased to $1.8 million, a 13% increase over the third quarter of 2023.Gross margin was 67%, a level consistently maintained over the past six quarters.Overall operating expenses were $3.4 million, flat with the prior year period. Chia

      11/12/24 4:05:00 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Announces Adoption of Shareholder Rights Agreement

      LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), ("LogicMark" or the "Company"), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced that it has entered into a Rights Agreement with Nevada Agency and Transfer Company (the "Rights Agreement") to protect shareholder rights and long-term shareholder value. This decision has been taken in response to recent actions by Winvest Investment Fund Management Corp. ("Winvest"), which recently disclosed in public filings with the U.S. Securities and Exchange Commission ("SEC") that it (i) purportedly ow

      11/1/24 4:44:26 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024

      LOUISVILLE, Ky., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, will issue a press release announcing its financial results for the third quarter ended September 30, 2024, after the market close on Tuesday, November 12, 2024. Ms. Chia-Lin Simmons, CEO, and Mr. Mark Archer, CFO, will host a live investor call and webcast the same day at 1:30 PM (PST) / 4:30 PM (EST) to review the results. Investors and analysts wishing to participate in the conference call must dial in here: Participant Toll-Free Dials: (800) 715-9871Participant Toll D

      10/31/24 9:15:49 AM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

      SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

      12/3/24 3:35:39 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by LogicMark Inc.

      SC 13G - LogicMark, Inc. (0001566826) (Subject)

      11/14/24 5:58:26 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

      SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

      11/12/24 3:45:20 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Large owner Winvest Investment Fund Management Corp. bought $114,112 worth of shares (1,257,257 units at $0.09), increasing direct ownership by 34% to 4,074,587 units (SEC Form 4)

      4/A - LogicMark, Inc. (0001566826) (Issuer)

      11/12/24 3:46:00 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • Large owner Winvest Investment Fund Management Corp. bought $306,880 worth of shares (3,464,987 units at $0.09), increasing direct ownership by 331% to 4,074,587 units (SEC Form 4)

      4 - LogicMark, Inc. (0001566826) (Issuer)

      10/18/24 9:31:15 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic Goals

      LOUISVILLE, Ky., April 28, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing care economy, today announced changes to its Board committee assignments. The LogicMark Board of Directors maintains an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. The Board comprises four independent non-executive directors who serve on the Committees and the Company's Chief Executive Officer (CEO), totaling five directors. The following new Board committee assignments reflect LogicMark's ongoing efforts to ensure that it

      4/28/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark Secures Approval to Deliver New Medical Alert with Cell Phone Tech to Veterans and Seniors Through U.S. General Services Administration

      LOUISVILLE, Ky., April 01, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), a provider of personal emergency response systems (PERS), health communications devices, and advanced technology for the growing personal care and safety economy, today announced a major breakthrough in senior care access. The company's Freedom Alert Max, its latest medical alert innovation, has secured approval to be procured through the U.S. General Services Administration (GSA). This approval empowers agencies, including the Veterans Administration (VA), to purchase and distribute the Freedom Alert Max to the communities they serve.  This latest milestone expands LogicMark's federal portfolio, with the F

      4/1/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Announces Closing of $14.4 Million Public Offering

      LOUISVILLE, Ky., Feb. 18, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), a provider of personal emergency response systems, health communications devices, and technology for the growing care economy, today announced the closing of its public offering. The public offering consisted of 2,260,000 units and 22,146,750 pre-funded units, with each unit consisting of one share of common stock (or for each pre-funded unit, one pre-funded warrant in lieu of one share of common stock), one Series C warrant to purchase one share of common stock and one Series D warrant to purchase one share of common stock. Gross proceeds, before deducting placement agent fees and estimated

      2/18/25 5:56:28 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    SEC Filings

    See more
    • SEC Form 424B3 filed by LogicMark Inc.

      424B3 - LogicMark, Inc. (0001566826) (Filer)

      5/7/25 4:06:19 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - LogicMark, Inc. (0001566826) (Filer)

      5/7/25 4:05:09 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 424B3 filed by LogicMark Inc.

      424B3 - LogicMark, Inc. (0001566826) (Filer)

      3/31/25 6:27:14 AM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Leadership Updates

    Live Leadership Updates

    See more
    • LogicMark Expands its Board of Directors by Naming Carine Schneider and Tom Wilkinson as Company's Innovative Product Pipeline Continues to Grow (Updated with Additional Details)

      LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of corporate governance, finance, operations, technology, M&A, advisory and CEO experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a

      10/31/23 11:54:15 AM ET
      $ASTC
      $LGMK
      $SONM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Industrial Specialties
      Health Care
    • Carine Schneider and Tom Wilkinson Join LogicMark's Board of Directors to Help Accelerate Growth

      LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of financial services, international business, and consulting experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a variety of succes

      10/31/23 8:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • Modivcare Announces Barbara Gutierrez to Join as Chief Financial Officer

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Barbara Gutierrez has agreed to join Modivcare as its Chief Financial Officer (CFO) with an expected start date of September 18, 2023. "I am delighted to announce the appointment of Barbara Gutierrez as our new Chief Financial Officer. Barb is an established finance leader within the healthcare industry, and I am confident that she will help Modivcare drive results as we advance our journey to becoming One Modivcare," said L. Heath Sampson, Chief Executive Of

      8/23/23 9:00:00 AM ET
      $LGMK
      $MODV
      Industrial Specialties
      Health Care
      Transportation Services
      Consumer Discretionary